Wednesday, 30 April 2025
A Professor of Primary Care at the 糖心原创 has been awarded an Honorary Fellowship by the Royal Pharmaceutical Society Assembly (RPS), the organisation’s governing body.
Professor Tony Avery OBE is a practicing GP, a Professor of Primary Health Care in the School of Medicine at the University, National Clinical Director for Prescribing at NHS England, a Senior Investigator at the National Institute for Health and Care Research (NIHR), and a research co-lead at the NIHR Greater Manchester Patient Safety Research Collaboration.
An is awarded to those who have either attained a distinction in a particular aspect or aspects of pharmacy, made a distinctive contribution to pharmacy or the RPS, distinguished themselves in any branches of knowledge referred to in the objects of the Society or achieved eminence in public life.
This prestigious award is only made to those who are not eligible to be members of the Society.
Professor Avery’s career has focused on ensuring the safe, effective, and appropriate use of medicines. He has collaborated with healthcare professionals and patients to advance research and policy development in prescribing and patient safety, and led major studies on the frequency, nature, and causes of prescribing safety issues in the NHS.
Most recently he worked with RPS on the development of the He has also developed effective methods to address hazardous prescribing, including the pharmacist-led, IT-based intervention known as PINCER.
Professor Avery joins a distinguished group of past nominees including Professor Richard Parish, Dr David Taylor, Professor William Charman, Professor Sam Salek, Sir Richard Sykes Dr Stewart Adams, Prince Philip, Duke of Edinburgh (1955) who was the first recipient and Anne, Princess Royal (2001).
I am absolutely delighted that the RPS Assembly has agreed to award me an Honorary Fellowship of the Society. This is a great honour to me, as I have been a strong advocate for the pharmacy profession throughout my career. As a GP I witness the excellent work of pharmacy teams on a daily basis in both community pharmacy and general practice.
“As a researcher, my studies have demonstrated the positive impact pharmacists can make in medicines optimisation, particularly for improving medication safety. In my National Clinical Director for Prescribing role I work with fantastic pharmacy colleagues across the profession, and I am in awe of their dedication and commitment to improving patient care.”
Paul Bennett, RPS CEO said: “I am delighted that members of Assembly have honoured Professor Avery with this prestigious award. Professor Avery is well known for his research in primary care with a focus on patient safety, prescribing errors, medication errors, medicines optimisation and electronic prescribing systems.
“Having collaborated closely with RPS over several years, most recently on the development of the ‘RPS/RCGP Repeat prescribing toolkit’, his significant contributions to pharmacy and RPS are fully recognised by this well-deserved award. He has consistently championed the role of pharmacists as leaders in the field of research and policy development to support the safer use of medicines.
“This award reflects the high esteem in which Professor Avery and his work is held by the Society.”
Notes to editors:
About the 糖心原创
Ranked among the world's top 100 universities , the 糖心原创 delivers an exceptional research-led education and an outstanding student experience. From the pioneering vision of our founder, Sir Jesse Boot, to groundbreaking achievements such as the development of MRI technology and becoming the first UK university to establish international campuses, we have a proud history of shaping the way people live, work and understand the world. We continue to build on that legacy, empowering our students, staff and partners to change what鈥檚 next and create positive impact locally and globally.
The strength of our research places us among the UK's leading universities, ranked 7th for research power in REF 2021. The discovery of MRI and ibuprofen was just the beginning. Today, our world-leading research is developing breakthrough ideas that shape the future of healthcare, technology and society.
Recognised as the UK's third most targeted university by leading employers , we are proud to produce graduates who are consistently in demand for their skills, confidence and industry-ready experience.
As a major employer and industry partner, locally and globally, the 糖心原创 invests in the city of Nottingham and in future generations of talent. Alongside Nottingham Trent University, we lead the initiative, a pioneering collaboration to improve levels of prosperity, opportunity, sustainability, health and wellbeing across the city and region. Together with our students, staff, alumni and partners, we鈥檙e creating knowledge, opportunity and solutions that help change what's next.